Search results for " treatment."

showing 10 items of 3290 documents

The minimally invasive supraorbital subfrontal key-hole approach for surgical treatment of temporomesial lesions of the dominant hemisphere

2009

INTRODUCTION: Surgery in the temporomesial region is generally performed using a subtemporal, transtemporal, or pterional-transsylvian approach. However, these approaches may lead to approach-related trauma of the temporal lobe and frontotemporal operculum with subsequent postoperative neurological deficits. Iatrogenic traumatisation is especially significant if surgery is performed in the dominant hemisphere. METHODS: During a five-year period between January 2003 and December 2007, we have approached the temporomesial region in 21 cases via the supraorbital approach. In 15 cases, the lesion was located within the dominant hemisphere, all lesions had space-occupying effects. In all cases, …

AdultMaleHemangioma Cavernous Central Nervous Systemmedicine.medical_specialtyNeurological examination610 Medicine & healthAstrocytomaHippocampusNeurosurgical ProceduresTemporal lobeLesionYoung Adult10180 Clinic for NeurosurgeryPostoperative ComplicationsPreoperative CaremedicineHumansMinimally Invasive Surgical ProceduresDominance CerebralSurgical treatmentOperculum (brain)Gangliogliomamedicine.diagnostic_testBrain Neoplasmsbusiness.industryGeneral MedicineMiddle AgedTemporal LobeFrontal LobeSurgery2746 SurgeryTreatment OutcomeHemiparesismedicine.anatomical_structure2728 Neurology (clinical)Frontal BoneParahippocampal GyrusFemaleSurgeryNeurology (clinical)medicine.symptombusinessOrbitCraniotomyParahippocampal gyrusDominant hemisphere
researchProduct

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C

2003

Occult HBV infection in subjects with chronic hepatitis C is related to more severe disease outcome. It has been suggested that it might reduce sensitivity to antiviral treatment.To assess in HBsAg negative subjects with chronic hepatitis C any effect of the presence of HBV genomes in the liver on the early kinetics of HCV-RNA under PEG-IFN plus ribavirin.Twenty-two anti-HCV and HCV-RNA positive subjects, with biopsy-proven chronic hepatitis C (M/F 15/7; 50 +/- 8.6 years, 16 genotype 1b) were given PEG-IFN alpha 2b 1.0 microg qw plus ribavirin (800 to 1,200 mg daily according to body weight) for an intended 52 week period. Early virological response was assessed over the first 4 weeks of th…

AdultMaleHepatitis B viruspegylated interferon-alphaGenotypeBiopsyHepacivirusInterferon alpha-2Virus ReplicationAntiviral AgentsPolyethylene GlycolsHepatitis B AntibodieRibavirinchronic hepatitis CHumansHepatitis B AntibodiesAntiviral AgentHepaciviruoccult HBV infection; chronic hepatitis C; pegylated interferon-alpha; viral dynamics; treatment responseoccult HBV infectiontreatment responseInterferon-alphaAlanine TransaminaseHepatitis B viruHepatitis C AntibodiesHepatitis C ChronicMiddle AgedRecombinant ProteinViral LoadHepatitis Bviral dynamicsRecombinant ProteinsTreatment OutcomeLiverDNA ViralRNA ViralDrug Therapy CombinationFemaleHepatitis C AntibodieHuman
researchProduct

Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series.

2013

AdultMaleHeredityAdolescentIntracellular Signaling Peptides and Proteinsautoinflammatory disorder phenotype NLRP12TRAPSMiddle AgedCryopyrin-Associated Periodic SyndromesPedigreePhenotypeTreatment OutcomeSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAItalyMutationHumansFemaleGenetic Predisposition to DiseaseAdolescent; Adult; Child Preschool; Cryopyrin-Associated Periodic Syndromes; Female; Genetic Predisposition to Disease; Heredity; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Italy; Male; Middle Aged; Pedigree; Phenotype; Treatment Outcome; MutationChildPreschoolImmunosuppressive Agents
researchProduct

In vivo evaluation of periodontal microcirculatory changes associated with endodontic treatment.

2014

The purpose of this study was to investigate in vivo the gingival microcirculatory changes associated with endodontic treatment using the continuous wave of condensation technique. MATERIALS AND METHODS: Twenty necrotic one canal roots of 20 cooperative patients of both sexes, aged between 20 and 43 years, were selected. All patients were examined by capillaroscopy before, immediately after endodontic treatment, and after 7 days. The last examination was carried out by the same operator, and repeated twice for each examined area: masticatory, buccal and labial mucosa corresponding to the endodontically treated root. All canals were prepared using a simultaneous technique with Ni-Ti files (M…

AdultMaleHot TemperatureGingivaVideo RecordingHemorrhageCAPILLAROSCOPYBody TemperatureMicroscopic AngioscopyYoung AdultSettore MED/28 - Malattie OdontostomatologicheNickelRoot Canal ObturationDental Pulp NecrosisHumansPERIODONTAL MICROCIRCULATIONCAPILLAROSCOPY; ENDODONTIC TREATMENT; PERIODONTAL MICROCIRCULATIONTitaniumWound HealingMouth MucosaCapillariesRoot Canal TherapyENDODONTIC TREATMENTFemaleRoot Canal PreparationDental AlloysFollow-Up StudiesEuropean journal of paediatric dentistry
researchProduct

An exploratory, prospective, open-label trial of ingenol mebutate gel 0.05% for the treatment of external anogenital warts

2017

BACKGROUND Anogenital warts (AGW) can cause physical discomfort and decreased quality of life. Recent case reports suggest that ingenol mebutate gel might be an effective treatment of AGW. OBJECTIVE To explore primarily the safety, and secondarily the efficacy of ingenol mebutate gel 0.05% in patients with AGW. METHODS This was an exploratory, open-label, 1-arm trial of ingenol mebutate gel 0.05% administered up to three times to patients with AGW. Safety was assessed by occurrence and severity of local skin reactions (LSRs) and treatment-related adverse events (AEs). Efficacy was assessed by complete clearance and reduction in AGW count 14 days after last treatment, and recurrence 12 weeks…

AdultMaleIngenol Mebutate Gelmedicine.medical_specialtyPopulationPainAntineoplastic AgentsDermatologyYoung Adult030207 dermatology & venereal diseases03 medical and health sciencesBlister0302 clinical medicineQuality of lifeRecurrenceInternal medicineSkin UlcermedicineEdemaHumansEffective treatmentIn patientProspective Studies030212 general & internal medicineAdverse effecteducationAgedAnus Diseaseseducation.field_of_studybusiness.industryMiddle AgedSafety profileTreatment OutcomeInfectious DiseasesCondylomata AcuminataErythemaFemaleDiterpenesGenital Diseases MaleOpen labelbusinessGelsGenital Diseases FemaleJournal of the European Academy of Dermatology and Venereology
researchProduct

Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence

2014

Opioid substitution treatment (OST) for opioid dependence may be limited by adverse events (AEs). Increasing the range of therapeutic options optimizes outcomes and facilitates patient management. An international, multi-center, two-phase study investigated the efficacy and safety of slow-release oral morphine (SROM) versus methadone in patients receiving methadone therapy for opioid dependence. In phase 1 (two way cross-over, 11 weeks each period) patients were randomized to SROM or methadone oral solution. In phase 2 (25 weeks), patients continued treatment with SROM (group A) or switched from methadone to SROM (group B). In total, 211 out of 276 completed phase 1 and 198 entered phase 2 …

AdultMaleInternational CooperationAdministration OralMedicine (miscellaneous)QT intervalHeroinOpiate Substitution TreatmentHumansMedicineIn patientOral morphineAdverse effectCross-Over StudiesMorphinebusiness.industryOpioid-Related DisordersEuropePsychiatry and Mental healthClinical PsychologyTreatment OutcomeOpioidTolerabilityDelayed-Action PreparationsAnesthesiaFemalePshychiatric Mental HealthbusinessMethadonemedicine.drugMethadoneJournal of Substance Abuse Treatment
researchProduct

Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*.

2006

Objectives: Oral deferiprone (L1) appears to be promising in the treatment of beta-thalassemia major (TM) patients. T2* magnetic resonance imaging (MRI) with a single measurement in the mid-ventricular septum was validated as a quantitative evaluation of myocardial iron overload. Previous studies suggested a marked heterogeneity of iron distribution in the myocardium. We set up a multislice multiecho T2* MRI for the detection of this heterogeneity. The aim of our study was to investigate differences between the L1 vs. the subcutaneous desferrioxamine (DF)-treated patients using this new approach.Methods: Thirty-six beta-TM patients (age 29 +/- 8 yr) underwent MRI. Eighteen patients received…

AdultMaleIron OverloadPyridonesCoefficient of variationDeferoxamineBETA THALASSEMIA MAJORchemistry.chemical_compoundMagneticsmultislice multiecho T2*MedicineHumansMultisliceDeferiproneReproducibilitymedicine.diagnostic_testbusiness.industryMyocardiumbeta-ThalassemiaBeta thalassemiaMagnetic resonance imagingHematologyGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance Imagingchelation treatmentmedicine.anatomical_structurechemistryVentricleFemalebusinessNuclear medicineDeferiproneEuropean journal of haematology
researchProduct

Laparoscopic adrenalectomy: preoperative data, surgical technique and clinical outcomes

2019

Background: laparoscopic adrenalectomy has become the standard treatment for adrenal lesions. The better clinical outcoms of laparoscopic technique are valid for treatment of small benign masses (< 5-6 cm), instead there are still open questions in literature regarding the correct management of larger lesions (> 6 cm) or in case of potentially malignant adrenal tumors. The aim of this study is to evaluate the outcomes of laparoscopic adrenalectomy in a referral surgical department for endocrine surgery. Methods: at the University Hospital Policlinico "P. Giaccone" of Palermo between January 2010 and December 2017 we performed a total of 81 laparoscopic adrenalectomy. We created a retr…

AdultMaleLaparoscopic surgerymedicine.medical_specialtyBlood transfusionmedicine.medical_treatmentOperative TimeAdrenal Gland Neoplasmslcsh:SurgeryLaparoscopic adrenalectomyHemorrhageAdrenal neoplasmAdrenal IncidentalomaLaparoscopic surgeryLesion03 medical and health sciencesPostoperative Complications0302 clinical medicineHumansCushing syndromeMedicinePostoperative PeriodIntraoperative ComplicationsAgedRetrospective StudiesAged 80 and overbusiness.industryResearchPatient SelectionAdrenalectomyStandard treatmentAdrenalectomylcsh:RD1-811General MedicineLength of StayMiddle AgedSurgeryEndocrine surgeryEndocrine surgeryDissection030220 oncology & carcinogenesisFemaleLaparoscopy030211 gastroenterology & hepatologySurgerymedicine.symptombusinessBMC Surgery
researchProduct

Evaluation of erlotinib treatment response in non-small cell lung cancer using metabolic and anatomic criteria

2016

BACKGROUND: In this paper the clinical value of PET for early prediction of tumor response to erlotinib in patients with advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen is evaluated. The aim was to compare the early metabolic treatment response using European Organization for Research and Treatment of Cancer (EORTC) 1999 recommendations and PET Response Criteria in Solid Tumors (PERCIST), and the standard treatment response using Response Evaluation Criteria in Solid Tumors (RECIST). METHODS: Twenty patients with stage IV NSCLCwere enrolled prospectively. PET/CT studies were performed before, then 48 hours, and 45 days after…

AdultMaleLung NeoplasmsTime FactorsAntineoplastic AgentsKaplan-Meier EstimateAdult; Aged; Antineoplastic Agents; Carcinoma Non-Small-Cell Lung; Disease-Free Survival; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Time Factors; Treatment OutcomeResponse evaluation criteria in solid tumorDisease-Free SurvivalErlotinib Hydrochloridenon–small cell lung cancerPositron Emission Tomography Computed TomographyHumansProspective StudiesNon-Small-Cell LungAgedCarcinomaMiddle AgedCarcinoma non-small-cell lungEORTCTreatment OutcomeRECISTResponse evaluation criteria in solid tumorsFemalePositron-emission tomographyPERCISTDiagnosi18F-FDG PET
researchProduct

Immediate effects of active cranio-cervical flexion exercise versus passive mobilisation of the upper cervical spine on pain and performance on the c…

2014

This study compared the immediate effects of an assisted plus active cranio-cervical flexion exercise (exercise group) versus a passive mobilisation plus assisted cranio-cervical flexion (mobilisation group) on performance of the cranio-cervical flexion test (CCFT), cervical range of motion (ROM) and pain in patients with chronic neck pain. Eighteen volunteers with chronic idiopathic neck pain participated in the study and were randomised to one of the two intervention groups. Current level of pain, cervical ROM and pain perceived during movement, pressure pain threshold (PPT) and surface electromyography (EMG) during performance of the CCFT were measured before and immediately after the in…

AdultMaleManipulation Spinalmedicine.medical_specialtyAnterior scaleneFlexion TestPhysical Therapy Sports Therapy and RehabilitationElectromyographyRisk AssessmentSeverity of Illness Index03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicineHumansIn patientSingle-Blind MethodRange of Motion ArticularPain Measurement030222 orthopedicsNeck painAnalysis of VarianceNeck Painmedicine.diagnostic_testbusiness.industryElectromyographyMotor controlGeneral MedicineMiddle AgedCervical spineExercise Therapybody regionsAtlanto-Occipital JointTreatment OutcomeChronic DiseasePhysical therapyFemaleActive treatmentmedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesManual therapy
researchProduct